v3.26.1
Debt Financing - Other (Details)
3 Months Ended
Jul. 31, 2025
USD ($)
Nov. 06, 2024
USD ($)
item
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Aug. 04, 2025
$ / shares
2024 Loan and Security Agreement          
Debt Financing          
Term loan   $ 50,000,000      
Interest rate variable (as a percent)   2.00%      
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]   us-gaap:PrimeRateMember      
Repayment terms of the loan   4 years      
Number of principal plus interest payments | item   6      
End of term charge (in percent)   6.35%      
Facility charge (in percent)   0.75%      
Interest expense     $ 480,000 $ 462,000  
Tranche one loan and security agreement          
Debt Financing          
Term loan   $ 15,000,000      
Tranche two loan and security agreement          
Debt Financing          
Term loan   $ 35,000,000      
Minimum | 2024 Loan and Security Agreement          
Debt Financing          
Cash coverage percentage         45.00%
Maximum | 2024 Loan and Security Agreement          
Debt Financing          
Interest rate stated (as a percent)   9.50%      
Cash coverage percentage         75.00%
Prepayment within 12 months of agreement closing date | 2024 Loan and Security Agreement          
Debt Financing          
Prepayment premium   3.00%      
Prepayment after 12 months but within 24 months of agreement closing date | 2024 Loan and Security Agreement          
Debt Financing          
Prepayment premium   2.00%      
Prepayment after 24 months of agreement closing date | 2024 Loan and Security Agreement          
Debt Financing          
Prepayment premium   1.00%      
Hercules Warrants          
Debt Financing          
Exercise Price | $ / shares     $ 3.58    
Warrants expiry term     5 years 7 months 9 days    
Hercules Warrants | 2024 Loan and Security Agreement          
Debt Financing          
Multiplier factor used to calculate common stock         0.04
Exercise Price | $ / shares         $ 3.58
Warrants expiry term         7 years
Secured Subordinated Convertible Promissory Note (the "Notes") | Medtronic | Loan Agreement          
Debt Financing          
Term loan $ 20,000,000        
Interest rate stated (as a percent) 11.00%        
Maturing or Repayment date of the Note Apr. 27, 2031        
Additional debt default interest rate (%) 2.00%        
Secured Subordinated Convertible Promissory Note (the "Notes") | Medtronic | FDA approval of a Medtronic device incorporating AVIM is achieved prior to the Repayment Date | Loan Agreement          
Debt Financing          
Debt extinguishment, percentage of revenue share amount (%) 15.00%        
Debt extinguishment, Revenue Share Credit payments $ 40,000,000